Given that PRMT5 is known to promote these stem cell traits,6,7 and that high levels are associated with a poor prognosis for breast cancer patients,4 we rationalised that PRMT5 activity could be a major driving force in the maintenance of BCSCs. Here, PRMT5 is linked to breast carcinoma.